POLISCOPE
Back to feed
Part ofMedicare →
HR6693FEDERALIN_COMMITTEE

Proposed Expansion of Medicare Lung Cancer Screening Coverage

Original title: Lung Cancer Screening and Prevention Act of 2023

December 17, 2024

MedicareHealthcareLung CancerPreventive ServicesFDA

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Where This Stands

Introduced
Committee
Floor Vote
Passed
Signed

Currently IN_COMMITTEE. The next step in the legislative lifecycle is Floor Vote.

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

The Frame

What this does

If passed, this bill would change the range of diagnostic tools available to Medicare enrollees for early lung cancer detection, potentially altering the scope of covered under .

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Medicare Part B enrollees

The bill changes the scope of preventive services available to these individuals by allowing for the potential coverage of additional lung cancer screening tests.

Secretary of Health and Human Services

The bill grants the Secretary new authority to determine coverage, frequency, and payment limits for additional lung cancer screening tests.

What changed

Current stage: IN_COMMITTEE.

What's next

Floor Vote.

Summary

This bill would allow Medicare to cover new types of lung cancer screening tests that have been cleared or approved by the FDA. It grants the Secretary of Health and Human Services the authority to determine which additional tests qualify as for Medicare beneficiaries.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Why It Matters

If passed, this bill would change the range of diagnostic tools available to Medicare enrollees for early lung cancer detection, potentially altering the scope of covered under .

Frequently Asked Questions

Does this bill automatically cover all new lung cancer tests?
No. It gives the Secretary of Health and Human Services the authority to provide coverage for tests that are FDA-cleared or approved, provided they meet specific criteria and follow the national coverage determination process.
When would these changes take effect?
The changes would take effect on the date the bill is enacted into law.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Sponsors

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Expansion of Preventive Coverage Authority

The bill shifts the mechanism for adding lung cancer screenings from a rigid statutory list to a more flexible administrative process under the Secretary of HHS.

Social Security ActSecretary of Health and Human Services

Connected Entities

personSteel“Co-sponsor of the bill”Map →
otherSocial Security Act“The law being amended”Map →
bill_number6693“Bill number”Map →
organizationAgency for Healthcare Research and Quality“Agency consulted in determining coverage”Map →
organizationFood and Drug Administration“Agency responsible for FDA clearance”Map →
other118th Congress“Congress in which the bill was introduced”Map →
personBucshon“Co-sponsor of the bill”Map →
organizationMedicare“The program receiving expanded coverage”Map →
personKilmer“Co-sponsor of the bill”Map →
personBuchanan“Introduced the bill in the House of Representatives”Map →

Analysis Score

0–100
  • Significance65
    How much this matters to a regular citizen
  • Controversy10
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz20
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record